Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 12/20 | 0.41 |
| ▸ | SOS1 | Q07889 | 4/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610197 | 0.81 | PDE10A (0.41) | PDE10ASOS1PIK3CD | |
| SCHEMBL1610335 | 0.80 | PDE10A (0.48) | PDE10ASOS1SLC6A3 | |
| SCHEMBL12712873 | 0.79 | PDE10A (0.52) | PDE10ASOS1PDE2A | |
| SCHEMBL12712859 | 0.79 | PDE10A (0.52) | PDE10ASOS1PDE2A | |
| SCHEMBL1610828 | 0.78 | PDE10A (0.48) | PDE10AKDM4EALDH1A1HPGDPDE2A | |
| SCHEMBL1609803 | 0.77 | PDE10A (0.50) | PDE10ASLC6A3KDM4EALDH1A1HPGD | |
| SCHEMBL1610170 | 0.77 | PDE10A (0.50) | PDE10ASOS1KDM4EALDH1A1HPGD | |
| SCHEMBL1610136 | 0.77 | AURKA (0.42) | PDE10ASOS1 | |
| SCHEMBL12712886 | 0.77 | PDE10A (0.46) | PDE10ASOS1 | |
| SCHEMBL12712871 | 0.77 | PDE10A (0.46) | PDE10ASOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | DDT, PNPO, CBR3 | PDE10A 1704/4885SOS1 355/4885SLC6A3 2437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.